T2DM is characterized by pancreatic β-cell dysfunction and insulin resistance, and is recognized as a multisystem metabolic disorder involving pathways such as the gut-brain axis, insulin/peripheral resistance, etc strongly correlated with obesity and cardiovascular diseases. The gene discussed is INS; the disease is Other metabolic disease.